Bluejay Diagnostics Inc. (BJDX)
Bluejay Diagnostics Statistics
Share Statistics
Bluejay Diagnostics has 554.01K shares outstanding. The number of shares has increased by -1.97% in one year.
| Shares Outstanding | 554.01K |
| Shares Change (YoY) | -1.97% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0.02% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 347 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 38.31K, so 3.1% of the outstanding shares have been sold short.
| Short Interest | 38.31K |
| Short % of Shares Out | 3.1% |
| Short % of Float | 3.1% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.12 and the forward PE ratio is -0.02. Bluejay Diagnostics's PEG ratio is 0.
| PE Ratio | -0.12 |
| Forward PE | -0.02 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 0.16 |
| P/FCF Ratio | -0.11 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Bluejay Diagnostics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.05, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.05 |
| Quick Ratio | 6.05 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | -0.03 |
| Debt / FCF | -0.03 |
| Interest Coverage | 8.71 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,102,542 |
| Employee Count | 7 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -99.04% in the last 52 weeks. The beta is 0.35, so Bluejay Diagnostics's price volatility has been higher than the market average.
| Beta | 0.35 |
| 52-Week Price Change | -99.04% |
| 50-Day Moving Average | 3.36 |
| 200-Day Moving Average | 7.12 |
| Relative Strength Index (RSI) | 43.59 |
| Average Volume (20 Days) | 1,181,808 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.17M |
| Net Income | -7.72M |
| EBITDA | -6.7M |
| EBIT | -8.54M |
| Earnings Per Share (EPS) | -42.08 |
Balance Sheet
The company has 4.3M in cash and 222.25K in debt, giving a net cash position of 4.08M.
| Cash & Cash Equivalents | 4.3M |
| Total Debt | 222.25K |
| Net Cash | 4.08M |
| Retained Earnings | -34.67M |
| Total Assets | 6.66M |
| Working Capital | 4.09M |
Cash Flow
In the last 12 months, operating cash flow was -7.82M and capital expenditures -306.78K, giving a free cash flow of -8.13M.
| Operating Cash Flow | -7.82M |
| Capital Expenditures | -306.78K |
| Free Cash Flow | -8.13M |
| FCF Per Share | -44.31 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BJDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for BJDX.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 18, 2024. It was a backward split with a ratio of 1:50.
| Last Split Date | Nov 18, 2024 |
| Split Type | backward |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | -9.41 |
| Piotroski F-Score | 1 |